vs

Side-by-side financial comparison of Civeo Corp (CVEO) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.

Civeo Corp is the larger business by last-quarter revenue ($161.6M vs $148.5M, roughly 1.1× OPKO HEALTH, INC.). Civeo Corp runs the higher net margin — -4.0% vs -21.1%, a 17.1% gap on every dollar of revenue. On growth, Civeo Corp posted the faster year-over-year revenue change (7.1% vs -19.2%). Civeo Corp produced more free cash flow last quarter ($14.5M vs $-28.6M). Over the past eight quarters, Civeo Corp's revenue compounded faster (-1.4% CAGR vs -7.5%).

The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

CVEO vs OPK — Head-to-Head

Bigger by revenue
CVEO
CVEO
1.1× larger
CVEO
$161.6M
$148.5M
OPK
Growing faster (revenue YoY)
CVEO
CVEO
+26.2% gap
CVEO
7.1%
-19.2%
OPK
Higher net margin
CVEO
CVEO
17.1% more per $
CVEO
-4.0%
-21.1%
OPK
More free cash flow
CVEO
CVEO
$43.0M more FCF
CVEO
$14.5M
$-28.6M
OPK
Faster 2-yr revenue CAGR
CVEO
CVEO
Annualised
CVEO
-1.4%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVEO
CVEO
OPK
OPK
Revenue
$161.6M
$148.5M
Net Profit
$-6.5M
$-31.3M
Gross Margin
22.7%
43.1%
Operating Margin
-0.1%
-25.8%
Net Margin
-4.0%
-21.1%
Revenue YoY
7.1%
-19.2%
Net Profit YoY
58.1%
-322.8%
EPS (diluted)
$-0.58
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVEO
CVEO
OPK
OPK
Q4 25
$161.6M
$148.5M
Q3 25
$170.5M
$151.7M
Q2 25
$162.7M
$156.8M
Q1 25
$144.0M
$150.0M
Q4 24
$151.0M
$183.6M
Q3 24
$176.3M
$173.6M
Q2 24
$188.7M
$182.2M
Q1 24
$166.1M
$173.7M
Net Profit
CVEO
CVEO
OPK
OPK
Q4 25
$-6.5M
$-31.3M
Q3 25
$-455.0K
$21.6M
Q2 25
$-3.3M
$-148.4M
Q1 25
$-9.8M
$-67.6M
Q4 24
$-15.4M
$14.0M
Q3 24
$-5.1M
$24.9M
Q2 24
$8.2M
$-10.3M
Q1 24
$-5.1M
$-81.8M
Gross Margin
CVEO
CVEO
OPK
OPK
Q4 25
22.7%
43.1%
Q3 25
25.7%
32.9%
Q2 25
25.3%
31.5%
Q1 25
20.4%
28.4%
Q4 24
18.6%
46.1%
Q3 24
21.4%
23.1%
Q2 24
25.4%
28.4%
Q1 24
21.5%
24.2%
Operating Margin
CVEO
CVEO
OPK
OPK
Q4 25
-0.1%
-25.8%
Q3 25
4.1%
31.7%
Q2 25
1.7%
-38.3%
Q1 25
-3.8%
-44.8%
Q4 24
-6.7%
-18.0%
Q3 24
0.0%
8.2%
Q2 24
6.9%
-33.9%
Q1 24
-1.1%
-41.2%
Net Margin
CVEO
CVEO
OPK
OPK
Q4 25
-4.0%
-21.1%
Q3 25
-0.3%
14.3%
Q2 25
-2.0%
-94.7%
Q1 25
-6.8%
-45.1%
Q4 24
-10.2%
7.6%
Q3 24
-2.9%
14.3%
Q2 24
4.4%
-5.7%
Q1 24
-3.1%
-47.1%
EPS (diluted)
CVEO
CVEO
OPK
OPK
Q4 25
$-0.58
$-0.04
Q3 25
$-0.04
$0.03
Q2 25
$-0.25
$-0.19
Q1 25
$-0.72
$-0.10
Q4 24
$-1.04
$0.02
Q3 24
$-0.36
$0.03
Q2 24
$0.56
$-0.01
Q1 24
$-0.35
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVEO
CVEO
OPK
OPK
Cash + ST InvestmentsLiquidity on hand
$14.4M
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$174.4M
$1.3B
Total Assets
$477.4M
$1.9B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVEO
CVEO
OPK
OPK
Q4 25
$14.4M
$364.4M
Q3 25
$12.0M
$412.0M
Q2 25
$14.6M
$267.3M
Q1 25
$28.4M
$428.8M
Q4 24
$5.2M
$426.6M
Q3 24
$17.9M
$400.1M
Q2 24
$7.4M
$40.6M
Q1 24
$16.8M
$75.6M
Total Debt
CVEO
CVEO
OPK
OPK
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$43.3M
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Q1 24
$350.1M
Stockholders' Equity
CVEO
CVEO
OPK
OPK
Q4 25
$174.4M
$1.3B
Q3 25
$182.5M
$1.3B
Q2 25
$209.4M
$1.3B
Q1 25
$220.7M
$1.3B
Q4 24
$236.4M
$1.4B
Q3 24
$282.2M
$1.4B
Q2 24
$297.4M
$1.4B
Q1 24
$297.4M
$1.3B
Total Assets
CVEO
CVEO
OPK
OPK
Q4 25
$477.4M
$1.9B
Q3 25
$491.1M
$2.0B
Q2 25
$508.8M
$2.0B
Q1 25
$423.8M
$2.1B
Q4 24
$405.1M
$2.2B
Q3 24
$477.6M
$2.3B
Q2 24
$483.2M
$2.0B
Q1 24
$513.1M
$2.0B
Debt / Equity
CVEO
CVEO
OPK
OPK
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.18×
0.32×
Q3 24
0.31×
Q2 24
0.14×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVEO
CVEO
OPK
OPK
Operating Cash FlowLast quarter
$19.3M
$-25.9M
Free Cash FlowOCF − Capex
$14.5M
$-28.6M
FCF MarginFCF / Revenue
8.9%
-19.3%
Capex IntensityCapex / Revenue
3.0%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$2.1M
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVEO
CVEO
OPK
OPK
Q4 25
$19.3M
$-25.9M
Q3 25
$13.8M
$-34.6M
Q2 25
$-2.3M
$-83.4M
Q1 25
$-8.4M
$-34.6M
Q4 24
$9.5M
$-44.4M
Q3 24
$35.7M
$-77.1M
Q2 24
$32.4M
$-26.4M
Q1 24
$6.0M
$-35.6M
Free Cash Flow
CVEO
CVEO
OPK
OPK
Q4 25
$14.5M
$-28.6M
Q3 25
$8.2M
$-37.8M
Q2 25
$-6.8M
$-86.7M
Q1 25
$-13.7M
$-37.7M
Q4 24
$1.8M
$-49.8M
Q3 24
$28.2M
$-85.0M
Q2 24
$27.0M
$-33.7M
Q1 24
$372.0K
$-40.0M
FCF Margin
CVEO
CVEO
OPK
OPK
Q4 25
8.9%
-19.3%
Q3 25
4.8%
-24.9%
Q2 25
-4.2%
-55.3%
Q1 25
-9.5%
-25.2%
Q4 24
1.2%
-27.1%
Q3 24
16.0%
-49.0%
Q2 24
14.3%
-18.5%
Q1 24
0.2%
-23.0%
Capex Intensity
CVEO
CVEO
OPK
OPK
Q4 25
3.0%
1.8%
Q3 25
3.3%
2.1%
Q2 25
2.8%
2.1%
Q1 25
3.7%
2.1%
Q4 24
5.1%
2.9%
Q3 24
4.2%
4.6%
Q2 24
2.8%
4.0%
Q1 24
3.4%
2.6%
Cash Conversion
CVEO
CVEO
OPK
OPK
Q4 25
Q3 25
-1.60×
Q2 25
Q1 25
Q4 24
-3.17×
Q3 24
-3.10×
Q2 24
3.93×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVEO
CVEO

Segment breakdown not available.

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

Related Comparisons